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SHORT COMMUNICATION
Coverage of clinic-based TB screening in South Africa  
may be low in key risk groups
N. McCreesh,1 I. Faghmous,1 C. Looker,1 P. J. Dodd,1,2 I. D. Plumb,1 K. Shanaube,3  
M. Muyoyeta,3,4 P. Godfrey-Faussett,5 H. Ayles,3,5 R. G. White1
South Africa has one of the highest tuberculosis (TB) burdens in the world, with an estimated disease 
prevalence in 2013 of 715 per 100 000 population.1 Dis-
ease incidence has been falling since 2008,2 but the de-
cline is slow, and new approaches are needed to accel-
erate the rate of decline. As part of its ‘90s’ strategy, on 
World TB Day 2015, the South African Ministry of 
Health proposed implementing screening of all health 
centre attendees for TB disease (unpublished speech 
given by Minister of Health A. Motsoaledi). This is a po-
tentially more cost-effective approach than communi-
ty-based screening programmes, as it is plausible that 
the prevalence of TB will be higher in clinic attendees 
than in the wider community, and the costs of reach-
ing clinic attendees are likely to be lower than more ac-
tive community-based screening programmes. Its pop-
ulation-level impact will be lower, however, if screening 
coverage is low among population subgroups that are 
at higher risk of developing TB disease. We investigated 
clinic attendance in adults in Western Cape, and in 
particular among two key risk groups: (young) men 
and people who visit bars.
STUDY POPULATION, DESIGN AND 
METHODS
The study sampling frame consisted of adults living in 
eight communities in Western Cape, South Africa, 
who were enrolled in the final Zambia/South Africa TB 
and acquired immune-deficiency syndrome Reduction 
(ZAMSTAR) prevalence survey.3 Four sampling enu-
meration areas (SEAs) from each ZAMSTAR commu-
nity were selected proportional to size, and 40 people 
were sampled at random from each SEA, stratified by 
sex and age. A full description of the sampling method 
is given elsewhere.4
Respondents were interviewed in their own homes 
using a structured questionnaire.4 The main purpose 
of the questionnaire was to collect data on contact 
and activity patterns relevant to Mycobacterium tuber-
culosis transmission. Respondents were also asked if 
they had visited a health care facility for any reason in 
the last 6 months.
Logistic regression was used to examine associa-
tions between a number of variables and clinic atten-
dance. Estimates were adjusted for age and sex and 
weighted to account for the stratified sampling 
design.
Ethical approval was obtained from the University 
of Stellenbosch Health Research Ethics Committee, 
Stellenbosch, South Africa (N04/10/173), the Univer-
sity of Zambia Biomedical Research Ethics Committee, 
Lusaka, Zambia (007-10-04), and the London School 
of Hygiene & Tropical Medicine Ethics Committee, 
London, UK (A211 3008).
RESULTS
A total of 1272 adults living in Western Cape were in-
terviewed. Results are presented for the 1271 adults 
who provided information on clinic attendance.
Overall, 55% (95% confidence interval [CI] 48–61) 
of women and 29% (95%CI 23–34) of men reported 
visiting a clinic in the past 6 months (Table 1). Adjust-
ing for sex, the odds of having visited a clinic in-
creased with age (P = 0.001), with people aged 18–25 
years having 0.47 (95%CI 0.31–0.70) times the odds 
compared to people aged 45 years. People who re-
ported attending bars had 0.45 (95%CI 0.33–0.60) 
times the odds of clinic attendance compared to peo-
ple who reported never attending bars.
Reported clinic attendance in the past 6 months 
was 50% for women in all age groups who never at-
tended bars and for women aged 45 years who at-
tended bars (Table 2). Reported attendance was 20% 
for all men aged 18–25 and for men aged 26–45 who 
attended bars.
DISCUSSION
We demonstrate that a clinic-based screening ap-
proach in Western Cape could achieve a potentially 
relatively high overall level of population coverage, 
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The South African Ministry of Health has proposed 
screening all clinic attendees for tuberculosis (TB). 
Amongst other factors, male sex and bar attendance are 
associated with higher TB risk. We show that 45% of 
adults surveyed in Western Cape attended a clinic within 
6 months, and therefore potentially a relatively high pro-
portion of the population could be reached through clin-
ic-based screening. However, fewer than 20% of all men 
aged 18–25 years, or men aged 26–45 who attend bars, 
attended a clinic. The population-level impact of clin-
ic-based screening may be reduced by low coverage 
among key risk groups.
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with 45% of adults reporting visiting a clinic in the 
last 6 months. In line with other studies from South 
Africa, we show that clinic attendance is lower among 
men than women,5,6 and is lower in younger than 
older adults.5 Coverage may be substantially lower 
than average in some population groups, in particular 
men aged 18–25 and men aged 26–45 who visit bars. 
Fewer than 20% of men in these groups may be 
reached by clinic-based screening programmes in any 
6-month period. This is of particular concern, as these 
demographic groups are at increased risk of contract-
ing TB,7,8 and passive case detection may be particu-
larly inadequate in people who consume alcohol,9 po-
tentially reducing the wider impact of clinic-based TB 
screening programmes.
We present data on clinic visits in the last 6 
months. Coverage will be higher over longer time peri-
ods, as a higher proportion of the population will visit 
a clinic in 12 months, for example, than in 6 months. 
For people who visit clinics less frequently, however, 
time between screenings will be longer, reducing the 
average impact of screening on the time between the 
onset of infectiousness and diagnosis. Coverage will 
also be lower if not all clinics screen 100% of 
attendees.
The main limitation of our approach is that data 
on both clinic and bar attendance were collected for 
similar time periods. This means that some of the ob-
served inverse association between bar and clinic at-
tendance may have resulted from illness that caused 
individuals to both attend a clinic and to stop attend-
ing bars, rather than a genuine reluctance or inability 
to attend clinics in people who visit bars. This may 
have biased the association upwards, but is unlikely 
to be responsible for more than a small proportion of 
the large observed difference in clinic attendance.
A second limitation of our findings is that only 
communities with a clinic could be selected for inclu-
sion in the original ZAMSTAR study. Clinic usage has 
been shown to decrease in South Africa as distance to 
the nearest clinic increases.10 Coverage may therefore 
be lower in communities with poorer access to health 
care, reducing overall coverage.
Clinic-based TB screening programmes have the po-
tential to reach nearly half the adult population over a 
6-month period in Western Cape, and may be a 
cost-effective way to reduce the prevalence of TB. Their 
effectiveness may be reduced by poor coverage in cer-
tain risk groups, however, and we recommend that 
clinic-based screening should be supplemented by 
case-finding programmes targeting key risk groups.
References
1 World Health Organization. Global tuberculosis report 2014. 
WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO, 2014.
2 Nanoo A, Izu A, Ismail N A, et al. Nationwide and regional in-
cidence of microbiologically confirmed pulmonary tuberculo-
sis in South Africa, 2004–2012: a time series analysis. Lancet 
Infect Dis 2015; 15: 1066–1076.
ACKNOWLEDGEMENTS
The authors would like to 
acknowledge the ZAMSTAR 
study team and R Dunbar, K 
Eames, J Edmunds, A 
Crampin and I Kleinschmidt, 
all of whom contributed 
advice in the design and 
analysis of the social contact 
survey. We would like to 
thank the Ministry of Health, 
District Health Management 
teams and the communities 
where the studies were 
undertaken for their help and 
advice.
NM was supported by the 
UK Medical Research Council 
(MR/J005088/1), London, 
UK. RGW, PJD, CL and IP 
were supported by the 
Consortium to Respond 
Effectively to the AIDS TB 
Epidemic funded by the Bill 
and Melinda Gates 
Foundation (19790.01), 
Seattle, WA, USA. RGW was 
also supported by the Bill 
and Melinda Gates 
Foundation (OPP1084276) 
and the UK Medical Research 
Council (G0802414, MR/
J005088/1).
Conflicts of interest: none 
declared.
This is an open access article 
distributed under the terms 
of the Creative Commons 
Attribution License, which 
permits unrestricted use, 
distribution, and 
reproduction in any medium, 
provided the original author 
and source are credited.
TABLE 1 Association between sex, age and bar attendance and clinic attendance within the previous 6 months
n (%)
Proportion who visited a clinic
% (95%CI)*
Odds ratio
(95%CI)*† P value
Sex
 Female 638 (50) 55 (48–61) 1 (reference)
 Male 633 (50) 29 (24–34) 0.33 (0.24–0.45) 0.001
Age, years
 45 296 (23) 57 (49–64) 1 (reference)
 26–45 578 (45) 42 (36–48) 0.53 (0.37–0.77) 0.001
 18–25 397 (31) 39 (33–45) 0.47 (0.31–0.70)
Ever go to bars?
 No 830 (65) 53 (48–58) 1 (reference)
 Yes 441 (35) 26 (22–32) 0.45 (0.33–0.60) 0.001
Total 1271 (100) 45 (41–50)
* Weighted to account for sampling method.
† Adjusted for age and sex.
CI = confidence interval.
TABLE 2 Proportion of people reporting clinic attendance in past 6 months by sex, age and bar attendance
Age
years
Men
n
Proportion visited clinic 
% (95%CI)*
Women
n
Proportion visited clinic 
% (95%CI)*
Ever go to bars 18–25 250 19 (13–29) 90 35 (21–53)
26–45 367 18 (12–26) 131 29 (18–43)
45 159 33 (17–53) 22 67 (38–87)
Never go to bars 18–25 335 20 (13–30) 502 55 (44–67)
26–45 285 34 (25–45) 714 59 (51–66)
45 294 49 (38–60) 368 63 (52–74)
* Weighted to account for sampling method.
CI = confidence interval.
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Le Ministère de la Santé d’Afrique du Sud a proposé de dépister la 
tuberculose (TB) chez tous les patients visitant un centre de santé. Parmi 
d’autres facteurs, le sexe masculin et la fréquentation des bars sont 
associés à un risque plus élevé de TB. Nous montrons que 45% des 
adultes dépistés dans la province du Cap Ouest s’étaient rendus dans 
un centre de santé au cours des 6 derniers mois et c’est pourquoi une 
proportion relativement élevée de la population pourrait être atteinte à 
travers un dépistage en centre de santé. Cependant, moins de 20% de 
tous les hommes âgés de 18–25 ans, ou des hommes âgés de 26–45 
ans qui fréquentent les bars, se rendent dans un centre de santé. 
L’impact sur la population de ce type de dépistage pourrait donc être 
réduit par une faible couverture parmi les groupes à risque majeur.
El Ministerio de Salud de Suráfrica propuso una detección sistemática 
de la tuberculosis (TB) a todas las personas que acudían a los 
consultorios. Entre los factores asociados con un mayor riesgo de 
padecer TB están el sexo masculino y la frecuentación de bares. El 
presente artículo pone de manifiesto que 45% de los adultos 
encuestados en la Ciudad del Cabo había acudido a un 
establecimiento de salud en los últimos 6 meses, por lo cual se pudo 
llegar a una proporción relativamente alta de la población mediante 
esta detección sistemática. Sin embargo, menos del 20% de todos los 
hombres entre los 18 y los 25 años, o entre los 26 y los 45 años de 
edad que frecuenta los bares, acudió a los establecimientos de salud. 
La repercusión a escala de la población de una detección sistemática 
realizada en los consultorios podría verse atenuada por una baja 
cobertura de los grupos más vulnerables.
Public Health Action (PHA) The voice for operational research.
Published by The Union (www.theunion.org), PHA provides a platform to 
fulfil its mission, ‘Health solutions for the poor’. PHA publishes high-quality 
scientific research that provides new knowledge to improve the accessibility, 
equity, quality and efficiency of health systems and services. 
e-ISSN 2220-8372
Editor-in-Chief: Dermot Maher, MD, Switzerland
Contact: pha@theunion.org
PHA website: http://www.theunion.org/what-we-do/journals/pha
Article submission: http://mc.manuscriptcentral.com/pha
